Tag: Ultromics

Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease

EchoGo Pro is an AI service for automated identification of coronary artery disease – FDA gives 510(K) clearance for EchoGo Pro, expanding the use of Ultromics’ EchoGo service to support clinicians diagnosing coronary artery disease – Every year in the U.S. over 800,000 people die from heart disease – accounting […]

Ultromics Lauded by Frost & Sullivan for Pioneering AI-based Cardiovascular Suite, EchoGo

The SaaS suite helps physicians automate key measurements and predict the occurrence of CAD, enabling clinicians to proactively recommend preventive actions that improve patient outcomes LONDON, Sept. 24, 2020 /PRNewswire/ — Based on its recent analysis of the global AI-based echocardiography market, Frost & Sullivan recognizes Ultromics with the 2020 Global New Product Innovation Award […]

Laurel Bridge Software and Ultromics Partnership Increases Accessibility to AI Solutions for Echocardiography

NEWARK, Del., Sept. 22, 2020 /PRNewswire/ — Laurel Bridge Software, a provider of software solutions that enable healthcare organizations to orchestrate their medical imaging workflows, announces a new partnership with Ultromics, a global health technology firm, which provides autonomous echocardiography analysis through innovative AI solutions. The Laurel Bridge AI Workflow Suite (AIWS) enables the Ultromics EchoGo suite of cloud-based AI […]

Ultromics Receives FDA Clearance for its AI-powered Decision Support System, EchoGo Core

AI automates cardiac analysis helping earlier detection of cardiovascular disease, enabling clinicians to improve patient care and outcomes OXFORD, England, Nov. 14, 2019 /PRNewswire/ — Ultromics, the UK-based health technology firm at the forefront of applying artificial intelligence to echocardiography, has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for […]